FDA approves drugs for cough, dysmenorrhea

02/28/2013 | RTT News

Hawthorn Pharmaceuticals gained federal approval for its VITUZ oral solution to treat cough and upper respiratory allergies in adults. Cypress Pharmaceuticals also received final approval for its mefenamic acid capsules USP, a generic version of Ponstel Capsules, to address mild-to-moderate pain with primary dysmenorrhea. Hawthorn and Cypress were subsidiaries of Pernix Therapeutics Holdings.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC